AbbVie

Open: 133.47 Close: 135.05 Change: 1.58

Can you guess what an AI found about AbbVie Stock.

How much time have you spent trying to decide whether investing in AbbVie? Many investors start with the dream of being free. They expect to find on the stock market an option to have time to develop their own interests and hobbies. That is, a way to escape a 9 to 5 job. However, investment is complex and investors end up spending whole days (and nights) trying to figure out which the right stock to invest is. The dream of stock investing becomes the nightmare of facing infinity amounts of information. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, …

Concept Map

Semantic Network

Stock Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenos.

Today's Summary

AbbVie Inc (ABBV) stock is down -1.49% while the S&P 500 has risen 1.15% as of 3:04 PM on Tuesday, Jun 27. European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for its migraine medication Qulipta.

Today's News

AbbVie Inc. (abbvie inc. gives back partnership announced | schools/education | independentnews.com. ppie – pusd and abbvie. gives back. partnership announced. AbbVie to present at Goldman Sachs 44th Annual Global Healthcare Conference on Wednesday, June 14, 2023. The Halftime Report traders give their top picks to watch for second half. AbbVie partnered with Heart of America to beautify the campus and create STEM (science, technology, engineering and mathematics) learning classrooms at Edison Elementary in Santa Ana. Abbvie is an employee volunteer program that is in its eighth year. AbbVie, Genmab Bi-Specific Lymphoma Data Tee Up Potential Challenge to Roche. AbbVie Inc (ABBV) stock is down -1.49% while the S&P 500 has risen 1.15% as of 3:04 PM on Tuesday, Jun 27. The European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for its migraine medication Qulipta. AbbVie share price is 133.23 USD today. The Abbvie stock price is forecast to RISE/FALL based on technical indicators. Analysts estimate an earnings decrease this quarter. Abbvie Inc (ABBV) stock price today, quote, latest discussions, interactive chart and news. AbbVie and Genmab announce positive topline results from phase 1/2 epcore™ nhl-1 trial evaluating epcoritamab in patients with relapsed/refractory follicular lymphoma. AbbVie squeezed about $96 billion in additional US Humira sales from 2017 through the first quarter of 2023, according to data compiled by Bloomberg LP. During its extended monopoly, Abbvie squeezed. about $ 96 billion in. additional US. Humira. sales. AbbVie closed the most recent trading day at $134.95, moving -0.71% from the previous trading session. Humira was a major revenue driver for Abbvie, contributing $3.5 billion out of the $12.2 billion total net revenue in the first quarter of 2023. Epcoritamab is being co-developed by AbbVie and Genmab as part of the companies oncology collaboration. The companies will share commercial responsibilities in the United States and Japan. AbbVie appoints Robert Michael as president and chief operating officer of the company. Lupin gets $25 million (around Rs 205 crore) from Abbvie Inc for meeting key development milestone for a product to treat hematological cancers. AbbVie (ABBV) Dips More Than Broader Markets: What You Should Know Jun. 26: Abbvie employees get hands-on in latest volunteering campaign. Analysis: New Humira rivals likely to hit US market with small discounts.

Stock Profile

"AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq, a JAK inhibitor to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, and ulcerative colitis; Imbruvica for the treatment of adult patients with blood cancers; and Venclexta/Venclyxto to treat hematological malignancies. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; and Ubrelvy for the acute treatment of migraine with or without aura in adults; Qulipta for episodic migraine. In addition, the company offers Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure(IOP) in patients with open angle glaucoma (OAG) or ocular hypertension; Restasis, a calcineurin inhibitor immunosuppressant indicated to increase tear production; and eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus (HCV) genotype 1-6 infection and HCV genotype 1 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; I-Mab Biopharma; Genmab A/S; Janssen Biotech, Inc.; and Genentech, Inc. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois."

Keywords

Are looking for the most relevant information about AbbVie? Investor spend a lot of time searching for information to make investment decisions in AbbVie. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about AbbVie are: AbbVie, Abbvie, Inc, Humira, give, announce, Genmab, and the most common words in the summary are: abbvie, stock, new, market, news, abbv, inc, . One of the sentences in the summary was: European Medicines Agencies Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for its migraine medication Qulipta.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #abbvie #stock #new #market #news #abbv #inc.